Literature DB >> 23478065

Neurons as targets for T cells in the nervous system.

Roland S Liblau1, Daniel Gonzalez-Dunia, Heinz Wiendl, Frauke Zipp.   

Abstract

Accumulating evidence shows that T cells penetrate the central nervous system (CNS) parenchyma in several autoimmune, infectious, and degenerative neurological diseases. The structural and functional consequences for CNS neurons of their encounter with activated T cells have been investigated in several experimental systems, including ex vivo co-cultures, electrophysiology, and in vivo imaging. Here, we review the modalities of neuron/T cell interactions. We substantiate the contention that T cells are directly responsible for neuronal damage in a large number of neurological diseases and discuss mechanisms of neuronal damage mediated by distinct T cell subsets, the impact of which differs depending on the disease. Finally, we describe how a better understanding of the mechanisms at play offers new possibilities for therapeutic intervention.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23478065     DOI: 10.1016/j.tins.2013.01.008

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  34 in total

Review 1.  Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy.

Authors:  Steven T Szabo; Michael J Thorpy; Geert Mayer; John H Peever; Thomas S Kilduff
Journal:  Sleep Med Rev       Date:  2018-11-08       Impact factor: 11.609

2.  Put to sleep by immune cells.

Authors:  Roland S Liblau
Journal:  Nature       Date:  2018-10       Impact factor: 49.962

3.  The role of TRAIL in fatigue induced by repeated stress from radiotherapy.

Authors:  Li Rebekah Feng; Simeng Suy; Sean P Collins; Leorey N Saligan
Journal:  J Psychiatr Res       Date:  2017-03-20       Impact factor: 4.791

4.  Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development.

Authors:  Alexander Ulges; Esther J Witsch; Gautam Pramanik; Matthias Klein; Katharina Birkner; Ulrike Bühler; Beatrice Wasser; Felix Luessi; Natascha Stergiou; Sarah Dietzen; Till-Julius Brühl; Toszka Bohn; Georg Bündgen; Horst Kunz; Ari Waisman; Hansjörg Schild; Edgar Schmitt; Frauke Zipp; Tobias Bopp
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-23       Impact factor: 11.205

Review 5.  Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease?

Authors:  Antoine Louveau; Sandro Da Mesquita; Jonathan Kipnis
Journal:  Neuron       Date:  2016-09-07       Impact factor: 17.173

Review 6.  Revisiting the Mechanisms of CNS Immune Privilege.

Authors:  Antoine Louveau; Tajie H Harris; Jonathan Kipnis
Journal:  Trends Immunol       Date:  2015-10       Impact factor: 16.687

Review 7.  Dendritic cells as therapeutic targets in neuroinflammation.

Authors:  Felix Luessi; Frauke Zipp; Esther Witsch
Journal:  Cell Mol Life Sci       Date:  2016-03-12       Impact factor: 9.261

8.  Axons are injured by antigen-specific CD8(+) T cells through a MHC class I- and granzyme B-dependent mechanism.

Authors:  Brian M Sauer; William F Schmalstieg; Charles L Howe
Journal:  Neurobiol Dis       Date:  2013-07-27       Impact factor: 5.996

Review 9.  The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?

Authors:  Kevin R Doty; Marie-Victoire Guillot-Sestier; Terrence Town
Journal:  Brain Res       Date:  2014-09-08       Impact factor: 3.252

10.  Exogenous LRRK2G2019S induces parkinsonian-like pathology in a nonhuman primate.

Authors:  Nadine Mestre-Francés; Nicolas Serratrice; Aurélie Gennetier; Gina Devau; Sandra Cobo; Stéphanie G Trouche; Pascaline Fontès; Charleine Zussy; Philippe De Deurwaerdere; Sara Salinas; Franck Jd Mennechet; Julien Dusonchet; Bernard L Schneider; Isabella Saggio; Vasiliki Kalatzis; M Rosario Luquin-Piudo; Jean-Michel Verdier; Eric J Kremer
Journal:  JCI Insight       Date:  2018-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.